|
Post by mnholdem on Oct 18, 2018 11:54:00 GMT -5
Brazil’s ANVISA to Eliminate Backlog of Applications
Posted 04 October 2018 | By Zachary Brennan
Brazilian drug regulator ANVISA said Wednesday at RAPS’ Regulatory Convergence that it would eliminate a backlog of new and generic drug applications by January 2019.
The elimination of the backlog will free the regulator up for new projects, and comes as more than 800 applications were backlogged as of January 2017, Raphael Sanches Pereira, general manager at ANVISA said.
Source: www.raps.org/news-and-articles/news-articles/2018/10/brazils-anvisa-to-eliminate-backlog-of-application
MnHoldem Note: I cannot get this link to work correctly. To locate the article, Google Brazil’s ANVISA to Eliminate Backlog of Applications
---
Could this mean that news about Afrezza in Brazil is mere weeks away?
|
|
|
Post by Omega on Oct 18, 2018 12:21:48 GMT -5
I think we were already scheduled to be approved by EoY. This is still great news though as it almost guarantees it.
I would assume we have some milestone payment upon ANVISA approval.
|
|
|
Post by mnkdfann on Oct 18, 2018 13:05:19 GMT -5
|
|
|
Post by goyocafe on Oct 18, 2018 13:13:50 GMT -5
The process feels more an administration dealing with an overcrowded prison than a logical process for approving drugs, but I’ll take it either way.
|
|
|
Post by #NoMoreNeedles on Jan 16, 2019 9:19:24 GMT -5
What's the latest?!
|
|